0001193125-18-299227.txt : 20181120 0001193125-18-299227.hdr.sgml : 20181120 20181015160204 ACCESSION NUMBER: 0001193125-18-299227 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20181015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (610) 981-6500 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 CORRESP 1 filename1.htm CORRESP

PHASEBIO PHARMACEUTICALS, INC.

1 Great Valley Parkway, Suite 30

Malvern, Pennsylvania 19355

October 15, 2018

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Attention:

Mary Beth Breslin

 

Irene Paik

 

Jim Rosenberg

 

Tabatha Mccullom

 

RE:

PhaseBio Pharmaceuticals, Inc.

 

Registration Statement on Form S-1

 

File No. 333-227474

Ladies and Gentlemen:

  PhaseBio Pharmaceuticals, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on Wednesday, October 17, 2018, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Darren DeStefano and Madison Jones of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

  Once the Registration Statement has been declared effective, please orally confirm that event with Darren DeStefano of Cooley LLP, counsel to the Registrant, at (703) 456-8034, or in his absence, Madison Jones at (202) 728-7087 or Jason Drory at (202) 842-7837.

[Signature Page Follows]

Very truly yours,
PHASEBIO PHARMACEUTICALS, INC.
By:  

/s/ Jonathan P. Mow

Name:   Jonathan P. Mow
Title:   Chief Executive Officer

 

cc:

John Sharp, PhaseBio Pharmaceuticals, Inc.

 

Christian E. Plaza, Cooley LLP

 

Darren K. DeStefano, Cooley LLP

 

Madison A. Jones, Cooley LLP

 

Edwin M. O’Connor, Goodwin Procter LLP

 

Seo Salimi, Goodwin Procter LLP

 

 

[Company Signature Page to Acceleration Request]